Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform recommendation. As of April 2, 2025, the average one-year price ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform recommendation. As of February 19, 2025, the average one-year price ...

NYSE:SVV opened at $7.59 on Friday. Savers Value Village has a 12 month low of $6.48 and a 12 month high of $18.93. The company has a current ratio of 1.04, a quick ratio of 0.86 and a debt-to ...

Cell therapy developer CARGO Therapeutics (NASDAQ:CRGX) traded higher on Tuesday after William Blair launched its coverage with ... “We believe near-term initiatives to expand CAR-T access ...

On Monday, William Blair reaffirmed a Market Perform rating ... sequential sales growth throughout the year. The company's initiatives, if successful, may set Kenvue on a course to reach its ...